Financial Times
Financial Times|11月 11, 2026 04:34
The biotech group most famous for its Covid-19 jab believes its personalised cancer vaccine, which is expected to win US regulatory approval next year, could be bigger than the bestselling oncology drug ever ft.trib.al/pNGqAcF(金融时报)
+3
Mentioned
Share To

Timeline

HotFlash

APP

X

Telegram

Facebook

Reddit

CopyLink

Hot Reads